Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, cash reserves at Alzamend Neuro Inc fell by 4.76m. Cash Flow from Financing totalled 3.65m or -- of revenues. In addition the company used 8.27m for operations while cash used for investing totalled 147.24k.
Cash flow per share | -10.39 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.41 |
---|---|
Tangible book value per share | -1.41 |
More ▼
Balance sheet in USDView more
Current ratio | 0.4914 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼